| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |